Q2 2017 13F Holders as of 6/30/2017
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
1.77B
-
Number of holders
-
1768
-
Total 13F shares, excl. options
-
1.1B
-
Shares change
-
+14.5M
-
Total reported value, excl. options
-
$80.1B
-
Value change
-
+$1.08B
-
Put/Call ratio
-
0.73
-
Number of buys
-
749
-
Number of sells
-
-782
-
Price
-
$72.51
Significant Holders of AbbVie Inc. - Common Stock (ABBV) as of Q2 2017
1,889 filings reported holding ABBV - AbbVie Inc. - Common Stock as of Q2 2017.
AbbVie Inc. - Common Stock (ABBV) has 1,768 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 1.1B shares
of 1.77B outstanding shares and own 62.49% of the company stock.
Largest 10 shareholders include Capital Research Global Investors (178M shares), VANGUARD GROUP INC (116M shares), BlackRock Inc. (94.1M shares), STATE STREET CORP (71.4M shares), NORTHERN TRUST CORP (21.1M shares), BANK OF AMERICA CORP /DE/ (18M shares), Bank of New York Mellon Corp (17.1M shares), FEDERATED INVESTORS INC /PA/ (15.1M shares), STATE FARM MUTUAL AUTOMOBILE INSURANCE CO (15.1M shares), and GEODE CAPITAL MANAGEMENT, LLC (15M shares).
This table shows the top 1768 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.